Aspira Women's Health Inc.
AWHL· OTC
Released Apr 1, 2026, after the close
10-K filed Apr 1, 2026, 91 days after period end · 0000926617-26-000020
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.23M | $2.35M | $2.13M | $2.15M |
| Net Income | -$3.37M | -$1.39M |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$3.09M |
| -$4.59M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.